{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:47:53Z","timestamp":1793836073211,"version":"4.6.1"},"reference-count":53,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T00:00:00Z","timestamp":1728691200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","contactlensjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contact Lens and Anterior Eye"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.clae.2024.102317","type":"journal-article","created":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T04:59:10Z","timestamp":1729141150000},"page":"102317","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Effect of 0.01% atropine eye drops combined with different optical treatments to control low myopia in Chinese children"],"prefix":"10.1016","volume":"48","author":[{"given":"Xindan","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyuan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongfei","family":"Ming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.clae.2024.102317_b0005","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.ophtha.2016.01.006","article-title":"Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050","volume":"123","author":"Holden","year":"2016","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.clae.2024.102317_b0010","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1001\/archopht.122.4.495","article-title":"The prevalence of refractive errors among adults in the United States, Western Europe, and Australia","volume":"122","author":"Kempen","year":"2004","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"10.1016\/j.clae.2024.102317_b0015","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1167\/iovs.62.5.2","article-title":"IMI impact of myopia","volume":"62","author":"Sankaridurg","year":"2021","journal-title":"Invest Ophthalmol vis Sci"},{"issue":"5","key":"10.1016\/j.clae.2024.102317_b0020","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1475-1313.2005.00298.x","article-title":"Myopia and associated pathological complications","volume":"25","author":"Saw","year":"2005","journal-title":"Ophthalmic Physiol Opt"},{"issue":"12","key":"10.1016\/j.clae.2024.102317_b0025","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1097\/IAE.0000000000001489","article-title":"Overview of the complications of high myopia","volume":"37","author":"Ikuno","year":"2017","journal-title":"Retina"},{"issue":"12","key":"10.1016\/j.clae.2024.102317_b0030","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1001\/jamaophthalmol.2016.4009","article-title":"Association of axial length with risk of uncorrectable visual impairment for Europeans with myopia","volume":"134","author":"Tideman","year":"2016","journal-title":"JAMA Ophthalmol"},{"issue":"9","key":"10.1016\/j.clae.2024.102317_b0035","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/j.ophtha.2010.01.020","article-title":"Prevalence and progression of myopic retinopathy in Chinese adults: the Beijing Eye Study","volume":"117","author":"Liu","year":"2010","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.clae.2024.102317_b0040","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.ophtha.2006.04.022","article-title":"Prevalence and causes of low vision and blindness in a Japanese adult population: the Tajimi Study","volume":"113","author":"Iwase","year":"2006","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.clae.2024.102317_b0045","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1136\/bjophthalmol-2018-313739","article-title":"Defocus incorporated multiple segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomized clinical trial","volume":"104","author":"Lam","year":"2020","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"10.1016\/j.clae.2024.102317_b0050","first-page":"405","article-title":"Controlling progression of myopia: optical and pharmaceutical strategies","volume":"7","author":"Sankaridurg","year":"2018","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"issue":"3","key":"10.1016\/j.clae.2024.102317_b0055","doi-asserted-by":"crossref","first-page":"M106","DOI":"10.1167\/iovs.18-25958","article-title":"IMI - interventions myopia institute: interventions for controlling myopia onset and progression report","volume":"60","author":"Wildsoet","year":"2019","journal-title":"Invest Ophthalmol vis Sci"},{"issue":"4","key":"10.1016\/j.clae.2024.102317_b0060","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ophtha.2015.11.010","article-title":"Efficacy comparison of 16 interventions for myopia control in children: a network meta-analysis","volume":"123","author":"Huang","year":"2016","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.clae.2024.102317_b0065","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/OPX.0b013e3181d951f7","article-title":"Peripheral refraction in myopic children after orthokeratology","volume":"87","author":"Queir\u00f3s","year":"2010","journal-title":"Optom vis Sci"},{"issue":"9","key":"10.1016\/j.clae.2024.102317_b0070","first-page":"404","article-title":"Orthokeratology for slowing myopia progression in children: a systematic review and meta-analysis of randomized controlled trials","volume":"49","author":"Tang","year":"2023","journal-title":"Eye Contact Lens"},{"issue":"9","key":"10.1016\/j.clae.2024.102317_b0075","first-page":"399","article-title":"Long-term efficacy of orthokeratology to control myopia progression","volume":"49","author":"Lv","year":"2023","journal-title":"Eye Contact Lens"},{"issue":"4","key":"10.1016\/j.clae.2024.102317_b0080","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/ICL.0000000000000520","article-title":"the role of orthokeratology in myopia control: a review","volume":"44","author":"Lipson","year":"2018","journal-title":"Eye Contact Lens"},{"issue":"1","key":"10.1016\/j.clae.2024.102317_b0085","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1186\/s12886-020-01746-w","article-title":"Efficacy and safety of atropine to control myopia progression: a systematic review and meta-analysis","volume":"20","author":"Zhao","year":"2020","journal-title":"BMC Ophthalmol"},{"issue":"2","key":"10.1016\/j.clae.2024.102317_b0090","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ophtha.2011.07.031","article-title":"Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2)","volume":"119","author":"Chia","year":"2012","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.clae.2024.102317_b0095","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ophtha.2015.07.004","article-title":"Five-year clinical trial on atropine for the treatment of myopia 2: myopia control with atropine 0.01% eyedrops","volume":"123","author":"Chia","year":"2016","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.clae.2024.102317_b0100","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1001\/jamaophthalmol.2023.5467","article-title":"Topical atropine for childhood myopia control: the atropine treatment long-term assessment study","volume":"142","author":"Li","year":"2024","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"10.1016\/j.clae.2024.102317_b0105","doi-asserted-by":"crossref","first-page":"e0281816","DOI":"10.1371\/journal.pone.0281816","article-title":"A comparison of myopia control in European children and adolescents with defocus incorporated multiple segments (DIMS) spectacles, atropine, and combined DIMS\/atropine","volume":"18","author":"Nucci","year":"2023","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.clae.2024.102317_b0110","first-page":"1197","article-title":"Safety of DIMS spectacle lenses and atropine as combination therapy for myopia progression","volume":"239","author":"Kaymak","year":"2022","journal-title":"Klin Monbl Augenheilkd"},{"issue":"1","key":"10.1016\/j.clae.2024.102317_b0115","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1186\/s12886-022-02635-0","article-title":"Combination of orthokeratology lens with 0.01% atropine in slowing axial elongation in children with myopia: a randomized double-blinded clinical trial","volume":"22","author":"Yu","year":"2022","journal-title":"BMC Ophthalmol"},{"issue":"5","key":"10.1016\/j.clae.2024.102317_b0120","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1159\/000510779","article-title":"Combined orthokeratology with atropine for children with myopia: a meta-analysis","volume":"64","author":"Wang","year":"2021","journal-title":"Ophthalmic Res"},{"issue":"5","key":"10.1016\/j.clae.2024.102317_b0125","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1080\/08164622.2021.1943318","article-title":"Adjunctive effects of orthokeratology and atropine 0.01% eye drops on slowing the progression of myopia","volume":"105","author":"Zhou","year":"2022","journal-title":"Clin Exp Optom"},{"issue":"1","key":"10.1016\/j.clae.2024.102317_b0130","doi-asserted-by":"crossref","first-page":"22311","DOI":"10.1038\/s41598-022-25599-z","article-title":"Synergistic effects of defocus-incorporated multiple segments and atropine in slowing the progression of myopia","volume":"12","author":"Huang","year":"2022","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.clae.2024.102317_b0135","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1038\/s41433-024-02987-5","article-title":"Comparison of the long-term effects of atropine in combination with Orthokeratology and defocus incorporated multiple segment lenses for myopia control in Chinese children and adolescents","volume":"38","author":"Tang","year":"2024","journal-title":"Eye (lond)"},{"issue":"8","key":"10.1016\/j.clae.2024.102317_b0140","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9082371","article-title":"The Combined Effect of Low-dose Atropine with Orthokeratology in Pediatric Myopia Control: Review of the Current Treatment Status for Myopia","volume":"9","author":"S\u00e1nchez-Gonz\u00e1lez","year":"2020","journal-title":"J Clin Med"},{"issue":"12","key":"10.1016\/j.clae.2024.102317_b0145","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1016\/j.jfma.2022.05.005","article-title":"Efficacy of atropine, orthokeratology, and combined atropine with orthokeratology for childhood myopia: A systematic review and network meta-analysis","volume":"121","author":"Tsai","year":"2022","journal-title":"J Formos Med Assoc"},{"issue":"10","key":"10.1016\/j.clae.2024.102317_b0150","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.oftal.2023.06.007","article-title":"Orthokeratology vs. orthokeratology combined with atropine for the control of myopia in children: systematic review","volume":"98","author":"Zambrano Peralta","year":"2023","journal-title":"Arch Soc Esp Oftalmol (engl Ed)"},{"issue":"8","key":"10.1016\/j.clae.2024.102317_b0155","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1167\/iovs.18-26247","article-title":"Axial growth and lens power loss at myopia onset in singaporean children","volume":"60","author":"Rozema","year":"2019","journal-title":"Invest Ophthalmol vis Sci"},{"issue":"11","key":"10.1016\/j.clae.2024.102317_b0160","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1001\/jamaophthalmol.2020.3451","article-title":"Association of age at myopia onset with risk of high myopia in adulthood in a 12-year follow-up of a Chinese cohort","volume":"138","author":"Hu","year":"2020","journal-title":"JAMA Ophthalmol"},{"issue":"11","key":"10.1016\/j.clae.2024.102317_b0165","doi-asserted-by":"crossref","first-page":"e0241759","DOI":"10.1371\/journal.pone.0241759","article-title":"Myopia progression varies with age and severity of myopia","volume":"15","author":"Verkicharla","year":"2020","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.clae.2024.102317_b0170","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/aos.13964","article-title":"Risk factors for high myopia: a 22-year follow-up study from childhood to adulthood","volume":"97","author":"P\u00e4rssinen","year":"2019","journal-title":"Acta Ophthalmol"},{"issue":"4","key":"10.1016\/j.clae.2024.102317_b0175","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/opo.12305","article-title":"Age of onset of myopia predicts risk of high myopia in later childhood in myopic Singapore children","volume":"36","author":"Chua","year":"2016","journal-title":"Ophthalmic Physiol Opt"},{"issue":"8","key":"10.1016\/j.clae.2024.102317_b0180","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.ophtha.2020.12.036","article-title":"Age effect on treatment responses to 0.05%, 0.025%, and 0.01% atropine: low-concentration atropine for myopia progression study","volume":"128","author":"Li","year":"2021","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.clae.2024.102317_b0185","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1186\/s13063-021-05825-1","article-title":"Efficacy of combined orthokeratology and 0.01% atropine for myopia control: the study protocol for a randomized, controlled, double-blind, and multicenter trial","volume":"22","author":"Yuan","year":"2021","journal-title":"Trials"},{"issue":"12","key":"10.1016\/j.clae.2024.102317_b0190","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1136\/bjo-2022-321272","article-title":"Effect of atropine, orthokeratology and combined treatments for myopia control: a 2-year stratified randomized clinical trial","volume":"107","author":"Xu","year":"2023","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.clae.2024.102317_b0195","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.clae.2018.10.026","article-title":"Adjunctive effect of orthokeratology and low dose atropine on axial elongation in fast-progressing myopic children-A preliminary retrospective study","volume":"42","author":"Chen","year":"2019","journal-title":"Cont Lens Anterior Eye"},{"issue":"5","key":"10.1016\/j.clae.2024.102317_b0200","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s00417-022-05901-5","article-title":"Axial length changes in progressive and nonprogressive myopic children in China","volume":"261","author":"Chen","year":"2023","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"5","key":"10.1016\/j.clae.2024.102317_b0205","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/opo.13159","article-title":"Normative data for axial elongation in Asian children","volume":"43","author":"Naduvilath","year":"2023","journal-title":"Ophthalmic Physiol Opt"},{"issue":"5","key":"10.1016\/j.clae.2024.102317_b0210","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s00417-019-04290-6","article-title":"Growth curves of myopia-related parameters to clinically monitor the refractive development in Chinese schoolchildren","volume":"257","author":"Sanz Diez","year":"2019","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"6","key":"10.1016\/j.clae.2024.102317_b0215","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1001\/jama.2022.24162","article-title":"Effect of Low-concentration atropine eyedrops vs placebo on myopia incidence in children: The LAMP2 randomized clinical trial","volume":"329","author":"Yam","year":"2023","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.clae.2024.102317_b0220","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1001\/jamaophthalmol.2023.2855","article-title":"Low-dose 0.01% atropine eye drops vs placebo for myopia control: A randomized clinical trial","volume":"141","author":"Repka","year":"2023","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"10.1016\/j.clae.2024.102317_b0225","first-page":"145","article-title":"The effect of refractive error on the accommodative response gradient","volume":"6","author":"McBrien","year":"1986","journal-title":"Ophthalmic Physiol Opt"},{"key":"10.1016\/j.clae.2024.102317_b0230","unstructured":"E. Ong KJC. Accommodation, Nearwork, Myopia. Optometric Extension Program Foundation. 1997:pp. 76-96,177-201."},{"key":"10.1016\/j.clae.2024.102317_b0235","unstructured":"Wallman J. Can myopia be prevented? 14th Biennial Research to Prevent Blindness Science Writers Seminar in Ophthalmology. 1997:pp. 50-52."},{"key":"10.1016\/j.clae.2024.102317_b0240","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.neuron.2004.08.008","article-title":"Homeostasis of eye growth and the question of myopia","author":"Wallman","year":"2004","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.clae.2024.102317_b0245","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/opo.12400","article-title":"Myopia progression control lens reverses induced myopia in chicks","volume":"37","author":"Irving","year":"2017","journal-title":"Ophthalmic Physiol Opt"},{"issue":"8","key":"10.1016\/j.clae.2024.102317_b0250","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1167\/iovs.63.8.10","article-title":"Peripheral refraction with toric orthokeratology and soft toric multifocal contact lenses in myopic astigmatic eyes","volume":"63","author":"Tomiyama","year":"2022","journal-title":"Invest Ophthalmol vis Sci"},{"issue":"6","key":"10.1016\/j.clae.2024.102317_b0255","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1167\/tvst.7.6.17","article-title":"A new method to analyze the relative corneal refractive power and its association to myopic progression control with orthokeratology","volume":"7","author":"Wang","year":"2018","journal-title":"Transl vis Sci Technol"},{"issue":"11","key":"10.1016\/j.clae.2024.102317_b0260","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1136\/bjo-2021-321005","article-title":"Control of myopia using diffusion optics spectacle lenses: 12-month results of a randomized controlled, efficacy and safety study (CYPRESS)","volume":"107","author":"Rappon","year":"2023","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"10.1016\/j.clae.2024.102317_b0265","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/opo.13031","article-title":"Myopia control with dual-focus soft contact lenses during the first year of measures to contain the COVID-19 pandemic","volume":"42","author":"Cabanes-Marti","year":"2022","journal-title":"Ophthalmic Physiol Opt"}],"container-title":["Contact Lens and Anterior Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1367048424002108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1367048424002108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T17:53:22Z","timestamp":1736272402000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1367048424002108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S1367048424002108"],"URL":"https:\/\/doi.org\/10.1016\/j.clae.2024.102317","relation":{},"ISSN":["1367-0484"],"issn-type":[{"value":"1367-0484","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of 0.01% atropine eye drops combined with different optical treatments to control low myopia in Chinese children","name":"articletitle","label":"Article Title"},{"value":"Contact Lens and Anterior Eye","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clae.2024.102317","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd on behalf of British Contact Lens Association.","name":"copyright","label":"Copyright"}],"article-number":"102317"}}